SCHEMBL7569225

SCHEMBL7569225

COc1ccc(S(=O)(=O)Nc2cc(C(=O)O)cc(OCCOC3CCCCO3)c2Oc2cc(OC)ccc2Cl)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
LMNA P02545 4/20 0.41
ALDH1A1 P00352 4/20 0.41
USP2 O75604 1/20 0.41
TSHR P16473 1/20 0.41
EDNRA P25101 3/20 0.41
EDNRB P24530 2/20 0.41
KDM4E B2RXH2 1/20 0.38
TP53 P04637 1/20 0.38
FABP4 P15090 1/20 0.37
PTGDR Q13258 1/20 0.37
PTGDR2 Q9Y5Y4 1/20 0.37
CREBBP Q92793 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
MAPK1 P28482 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CYP2C9 P11712 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7573973 0.94 CYP2C9 (0.42) MEN1KMT2ALMNAALDH1A1USP2
SCHEMBL7569615 0.90 EDNRA (0.47) LMNAALDH1A1USP2TSHREDNRA
SCHEMBL7568187 0.89 EDNRA (0.44) LMNAALDH1A1USP2TSHREDNRA
SCHEMBL7570771 0.87 TSHR (0.46) MEN1KMT2ALMNAALDH1A1USP2
SCHEMBL8332573 0.84 MEN1 (0.47) MEN1KMT2AEDNRAEDNRBCREBBP
SCHEMBL7570355 0.84 EDNRB (0.49) MEN1KMT2ALMNAALDH1A1USP2
SCHEMBL7565796 0.84 EDNRA (0.47) KMT2ALMNAALDH1A1USP2TSHR
SCHEMBL7566496 0.83 EDNRB (0.55) LMNAALDH1A1TSHREDNRAEDNRB
SCHEMBL7566574 0.81 EDNRA (0.44) EDNRAEDNRBNPC1RAB9A
SCHEMBL7572698 0.79 NPC1 (0.41) MEN1KMT2AALDH1A1USP2EDNRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0799206-B1 ARYL- AND HETARYL-SULFONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ENDOTHELIN ANTAGONISTS HOFFMANN LA ROCHE (CH) 2002-09-11 EP disclosed
US-6133442-A FOR THE TREATMENT OF DISORDERS WHICH ARE ASSOCIATED WITH ENDOTHELIN ACTIVITIES, ESPECIALLY CIRCULATORY DISORDERS SUCH AS HYPERTENSION, ISCHAEMIA, VASOSPASMS AND ANGINA PECTORIS HOFFMANN-LA ROCHE INC. (US) 2000-10-17 US disclosed
US-5962682-A Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists HOFFMANN-LA ROCHE INC. (US) 1999-10-05 US disclosed
EP-0799206-A1 ARYL- AND HETARYL-SULFONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ENDOTHELIN ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 1997-10-08 EP disclosed
WO-1996019455-A1 ARYL- AND HETARYL-SULFONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ENDOTHELIN ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 1996-06-27 WO disclosed